electrophysiology catheters market is projected to grow from US$ 6.45 billion in 2022 to US$ 22.3 billion by 2032. Global electrophysiology catheters market is driven by growing geriatric population and increasing incidence of cardiac arrhythmia across the globe. Moreover, technological advancements such as the launch of wireless technology in a diagnosis of arrhythmias have proven to be a milestone in global electrophysiology catheters market. Electrophysiology catheters are constantly used with cardiac ablation procedures. After the number of new FDA approvals in 2010, the number of cardiac ablation procedures has sharply increased. This rise in a number of cardiac ablation procedures would provide opportunities for the growth of the global electrophysiology catheters market.

The report "Electrophysiology Catheters Market, By Type (Conventional Ep Diagnostic Catheters, Advanced Ep Diagnostic Catheters, and Ultrasound Ep Diagnostic Catheters), By Application (Congenital Heart Defect, Heart Failure, and Ailments of Blood Vessels), and Region - Global Forecast to 2029"

Key Highlights:

• On July 2019, Biotronik, Inc. has announced FDA approval of the BIOMONITOR III injectable cardiac monitor (ICM). BIOMONITOR III is used document suspected arrhythmia or unexplained syncope with enabling fast diagnosis and appropriate treatment, and to increased clarity.
• On August 2019, Boston Scientific Corporation has announced the completion of its acquisition with BTG plc. BTG commercializes and develops products used in minimally-invasive procedures targeting vascular diseases and cancer, as well as specialty pharmaceuticals.

Key Market Insights from the report:          

The global electrophysiology catheters market accounted for US$ 6.45 billion in 2019 and is projected to register a moderate CAGR of 12.4% over the forecast period. The market report has been segmented on the basis of type, application, and region.

• By type, the global electrophysiology catheters market is segmented into conventional Ep diagnostic catheters, advanced Ep diagnostic catheters, and ultrasound Ep diagnostic catheters.
• By application, the global electrophysiology catheters market is categorized into congenital heart defect, heart failure, and ailments of blood vessels.
• By region, North America is expected to dominate the global electrophysiology catheters market due to high patient volumes over the forecast period. Europe is accounted to hold second largest market share in the global market over the forecast period, owing to increasing prevalence of cardiovascular diseases. Asia-Pacific is expected to witness significant growth in electrophysiology catheters market due to growing presence of key players and technological advancements in the country.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on " Global Electrophysiology catheters Market”, By Type (Conventional Ep Diagnostic Catheters, Advanced Ep Diagnostic Catheters, and Ultrasound Ep Diagnostic Catheters), By Application (Congenital Heart Defect, Heart Failure, and Ailments of Blood Vessels), and by Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - forecast till 2029

The prominent player operating in the global electrophysiology catheters market includes APT Medical Inc., Beijing Amsino Medical Co., Ltd., Beijing Demax Medical Technology Co., Ltd., Biosense Webster, Inc., Biotronik, Inc., Boston Scientific Corporation, CathRx Ltd., Japan Lifeline Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., and Medtronic plc.

To know more
Contact Us:
Sales
Prophecy Market Insights
 U.S.  1 860 531 2574
RoW: 917775049802
Email- sales@prophecymarketinsights.com
Website- www.prophecymarketinsights.com